Does Rexulti (brexpiprazole) cause memory loss?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Does Rexulti Cause Memory Loss?

Rexulti (brexpiprazole) does not cause memory loss and may actually improve cognitive function. In fact, the FDA label specifically warns about "potential for cognitive and motor impairment" only in the context of operating machinery until patients know how they respond to the medication, not as a direct cognitive side effect 1.

Evidence Supporting Cognitive Safety

Preclinical and Clinical Data on Cognition

Brexpiprazole has demonstrated procognitive effects in multiple preclinical studies. In animal models of cognitive impairment (using phencyclidine to induce deficits similar to schizophrenia), brexpiprazole reversed cognitive impairment in both novel object recognition and attentional set-shifting tests 2. These effects were mediated through its 5-HT1A receptor partial agonist activity 3.

The preclinical pharmacological profile suggests brexpiprazole has improvement effects on cognitive dysfunction, distinguishing it from other antipsychotics 4.

Real-World Clinical Trial Data

In the most recent pooled analysis of clinical trials in patients with Alzheimer's dementia and agitation (2025), involving over 1,000 participants treated for up to 24 weeks, there was no worsening of cognition observed with brexpiprazole treatment 5. This is particularly significant because this population is already cognitively impaired and highly vulnerable to medication side effects.

Important Context: Antipsychotic Class Effects

While the FDA label mentions "cognitive impairment" as a potential concern with antipsychotic polypharmacy 1, the guideline evidence clarifies this is not specific to brexpiprazole. Cognitive decline associated with antipsychotics is primarily driven by:

  • Total antipsychotic dose rather than the use of multiple agents 6
  • Disease severity requiring more intensive treatment, not the medications themselves 6
  • The data on antipsychotic-induced cognitive decline remains conflicting and may reflect confounding by indication 6

Clinical Implications

You should not avoid brexpiprazole due to memory concerns. The evidence suggests:

  • Brexpiprazole has a favorable cognitive profile compared to other antipsychotics
  • No cognitive worsening was observed in vulnerable elderly populations with dementia
  • Preclinical data suggests potential cognitive benefits through 5-HT1A receptor activity

What to Monitor

Rather than memory loss, focus on the actual documented side effects from the FDA label 1:

  • Sedation/somnolence (which could indirectly affect attention, not memory)
  • Orthostatic hypotension (particularly early in treatment)
  • Metabolic changes
  • Extrapyramidal symptoms (though incidence is low)

If a patient reports subjective memory problems on brexpiprazole, consider alternative explanations such as underlying disease progression, depression, sedation affecting attention rather than memory consolidation, or other concomitant medications.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.